tradingkey.logo

Neogen Corp

NEOG
View Detailed Chart

5.670USD

+0.210+3.85%
Close 09/18, 16:00ETQuotes delayed by 15 min
1.23BMarket Cap
LossP/E TTM

Neogen Corp

5.670

+0.210+3.85%
Intraday
1m
30m
1h
D
W
M
D

Today

+3.85%

5 Days

+1.43%

1 Month

+4.42%

6 Months

-39.03%

Year to Date

-53.29%

1 Year

-66.39%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated2025-09-17

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
81 / 207
Overall Ranking
226 / 4723
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 4 analysts
Buy
Current Rating
6.500
Target Price
+23.34%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Neogen Corporation is engaged in developing, manufacturing and marketing a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. Its Food Safety segment consists primarily of diagnostic test kits and complementary products sold to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues and general sanitation concerns. The Company’s Animal Safety segment is engaged in the development, manufacture, marketing, and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services for the worldwide animal safety market.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 4675.01.
Overvalued
The company’s latest PE is -1.08, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 240.23M shares, decreasing 15.11% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 23.53M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.77.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Neogen Corporation is engaged in developing, manufacturing and marketing a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. Its Food Safety segment consists primarily of diagnostic test kits and complementary products sold to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues and general sanitation concerns. The Company’s Animal Safety segment is engaged in the development, manufacture, marketing, and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services for the worldwide animal safety market.
Ticker SymbolNEOG
CompanyNeogen Corp
CEOMr. Mikhael Nassif
Websitehttps://www.neogen.com/
KeyAI